Published online Apr 26, 2020. doi: 10.12998/wjcc.v8.i8.1444
Peer-review started: December 13, 2019
First decision: February 20, 2020
Revised: March 5, 2020
Accepted: April 1, 2020
Article in press: April 1, 2020
Published online: April 26, 2020
Processing time: 133 Days and 8.4 Hours
Preeclampsia is a common perinatal complication and is one of the major hazards of pregnancy. Cesarean section is a common way to end pregnancy in patients with preeclampsia. Spinal anesthesia can provide satisfactory anesthesia for cesarean section, but its maternal vital sign fluctuations, such as low blood pressure, often affect maternal and fetal blood supply, which can lead to bad outcomes. Therefore, better monitoring and early treatment are the focus of anesthesia management during cesarean section for preeclampsia patients.
Ropivacaine is one of the more common local anesthetics for spinal anesthesia in cesarean section. Based on current clinical practice and research, it can provide satisfactory anesthesia for cesarean section, but the specific effects of ropivacaine on the hemodynamics of patients with preeclampsia undergoing cesarean section are unknown. Understanding the effects of ropivacaine on such patients can help improve anesthesia management, reduce related complications, and increase maternal satisfaction.
The aim of this study was to record and analyze vital sign data in women with preeclampsia undergoing cesarean delivery after spinal anesthesia using ropivacaine.
We adopted a moderately invasive monitoring system to observe the changes in cardiac output, heart rate, blood pressure, central venous pressure, and heart stroke volume of patients with preeclampsia during cesarean delivery under spinal anesthesia using ropivacaine at multiple time points. These changes were then analyzed.
In women with preeclampsia who received spinal anesthesia with ropivacaine, we found several trends. Overall changes in the above indicators were mild throughout the operation, with only three out of ten patients needing medication to raise blood pressure at any time during the procedure. At the same time, ropivacaine provided satisfactory anesthesia to ensure a comfortable and smooth operation. No maternal or neonatal complications were observed during this study, except temporary episodes of low blood pressure.
This study confirms that ropivacaine can provide satisfactory anesthesia and stable blood pressure during cesarean section in patients with preeclampsia. This study is the first to describe vital sign trends in detail in preeclamptic women receiving spinal anesthesia with ropivacaine. We hope that these data can support future perioperative monitoring and interventions.